Evercore ISI Remains a Buy on Cardinal Health (CAH)

In a report released today, Elizabeth Anderson CFA from Evercore ISI reiterated a Buy rating on Cardinal Health, with a price target of $240.00.

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Anderson CFA covers the Healthcare sector, focusing on stocks such as Humana, Align Tech, and Doximity. According to TipRanks, Anderson CFA has an average return of -3.5% and a 45.11% success rate on recommended stocks.

In a report released today, TD Cowen also assigned a Buy rating to the stock with a $255.00 price target.

Based on Cardinal Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $60.94 billion and a net profit of $399 million. In comparison, last year the company earned a revenue of $54.88 billion and had a net profit of $506 million

Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CAH in relation to earlier this year. Most recently, in February 2026, Aaron E Alt, the CFO of CAH sold 4,242.00 shares for a total of $947,556.06.